- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/32 - Alcohol-abuse
Patent holdings for IPC class A61P 25/32
Total number of patents in this class: 542
10-year publication summary
13
|
24
|
41
|
50
|
50
|
37
|
46
|
44
|
30
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
H. Lundbeck A/S | 1247 |
13 |
Takeda Pharmaceutical Company Limited | 2945 |
12 |
Banyu Pharmaceutical Co., Ltd. | 84 |
10 |
The Regents of the University of California | 19479 |
9 |
Hoffmann-La Roche Inc. | 3252 |
6 |
Janssen Pharmaceutica N.V. | 3625 |
6 |
Alkermes Pharma Ireland Limited | 289 |
6 |
Mitsubishi Tanabe Pharma Corporation | 575 |
6 |
The Regents of the University of Colorado, a body corporate | 2520 |
6 |
Texas Tech University System | 541 |
6 |
Metabomed Ltd. | 13 |
6 |
Purdue Research Foundation | 3472 |
5 |
Biohit Oyj | 45 |
5 |
Daiichi Sankyo Company, Limited | 1863 |
5 |
Indivior UK Limited | 200 |
5 |
Sophrosyne Pharmaceuticals Limited | 7 |
5 |
Aegis Therapeutics, LLC | 62 |
4 |
Arena Pharmaceuticals, Inc. | 371 |
4 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2581 |
4 |
Laboratorio Farmaceutico C.T. S.r.l. | 19 |
4 |
Other owners | 415 |